A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age
Clinical trial NCT02719743 · COMPLETED
Trial details
- NCT number
- NCT02719743
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-07
- Primary completion
- 2018-02-13
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.